Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease
Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease
About this item
Full title
Author / Creator
Publisher
New York, NY: Am Thoracic Soc
Journal title
Language
English
Formats
Publication information
Publisher
New York, NY: Am Thoracic Soc
Subjects
More information
Scope and Contents
Contents
The oral phosphodiesterase-4 (PDE4) inhibitor, roflumilast, can improve lung function in moderate chronic obstructive pulmonary disease (COPD). Whether treatment is effective in more severe COPD (GOLD [Global Initiative for Chronic Obstructive Lung Disease] stages III and IV) over a longer period is unknown.
To determine whether roflumilast impr...
Alternative Titles
Full title
Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_70694134
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70694134
Other Identifiers
ISSN
1073-449X
E-ISSN
1535-4970
DOI
10.1164/rccm.200610-1563OC
